Chiari Malformation Type I: A Case-Control Association Study of 58 Developmental Genes

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Urbizu, Aintzane ^a   Toma, Claudio ^c,d   Poca, Maria A ^b   Sahuquillo, Juan ^b   Cuenca León, Ester ^a   Cormand, Bru ^c,d   Macaya, Alfons ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR 1; NOTCH RECEPTOR; RETINOIC ACID; TRANSCRIPTION FACTOR CDX1; VASCULOTROPIN RECEPTOR 2; WNT PROTEIN;

ADULT; ALDH1A2 GENE; ARNOLD CHIARI MALFORMATION; ARTICLE; BMPR1A GENE; CASE CONTROL STUDY; CDX1 GENE; CLINICAL FEATURE; CONTROLLED STUDY; DEVELOPMENTAL GENE; FEMALE; FGFR1 GENE; FLT1 GENE; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; KDR GENE; LFNG GENE; MAJOR CLINICAL STUDY; MALE; MSGN1 GENE; NKD2 GENE; NOG GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; RARA GENE; RARG GENE; RBPJ1 GENE; RDH10 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARNOLD-CHIARI MALFORMATION; CASE-CONTROL STUDIES; CRANIAL FOSSA, POSTERIOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, DEVELOPMENTAL; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; MORPHOGENESIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINAL DEHYDROGENASE; RHOMBENCEPHALON; RISK; SOMITES;

EID: 84874329034     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057241     Document Type: Article

References (74)

1. Chiari H, (1987) Concerning alterations in the cerebellum resulting from cerebral hydrocephalus. 1891. Pediatr Neurosci 13: 3-8.
2. Barkovich AJ, Wippold FJ, Sherman JL, Citrin CM, (1986) Significance of cerebellar tonsillar position on MR. AJNR Am J Neuroradiol 7: 795-799.
3. Milhorat TH, Chou MW, Trinidad EM, Kula RW, Mandell M, et al. (1999) Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients. Neurosurgery 44: 1005-1017.
4. Tubbs RS, Beckman J, Naftel RP, Chern JJ, Wellons JC 3rd, et al. (2011) Institutional experience with 500 cases of surgically treated pediatric Chiari malformation Type I. J Neurosurg Pediatr 7: 248-256.
5. Greenlee JD, Donovan KA, Hasan DM, Menezes AH, (2002) Chiari I malformation in the very young child: the spectrum of presentations and experience in 31 children under age 6 years. Pediatrics 110: 1212-1219.
6. Martinot A, Hue V, Leclerc F, Vallee L, Closset M, et al. (1993) Sudden death revealing Chiari type 1 malformation in two children. Intensive care medicine 19: 73-74.
7. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, et al. (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357: 1821-1828.
8. Morris Z, Whiteley WN, Longstreth WT Jr, Weber F, Lee YC, et al. (2009) Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. Bmj 339: b3016.
9. Speer MC, George TM, Enterline DS, Franklin A, Wolpert CM, et al. (2000) A genetic hypothesis for Chiari I malformation with or without syringomyelia. Neurosurg Focus 8: E12.
10. Meadows J, Kraut M, Guarnieri M, Haroun RI, Carson BS, (2000) Asymptomatic Chiari Type I malformations identified on magnetic resonance imaging. J Neurosurg 92: 920-926.
11. Marin-Padilla M, Marin-Padilla TM, (1981) Morphogenesis of experimentally induced Arnold-Chiari malformation. J Neurol Sci 50: 29-55.
12. Barry A, Patten BM, Stewart BH, (1957) Possible factors in the development of the Arnold-Chiari malformation. J Neurosurg 14: 285-301.
13. Gardner WJ, Goodall RJ, (1950) The surgical treatment of Arnold-Chiari malformation in adults; an explanation of its mechanism and importance of encephalography in diagnosis. J Neurosurg 7: 199-206.
14. McLone DG, Knepper PA, (1989) The cause of Chiari II malformation: a unified theory. Pediatr Neurosci 15: 1-12.
15. Nishikawa M, Sakamoto H, Hakuba A, Nakanishi N, Inoue Y, (1997) Pathogenesis of Chiari malformation: a morphometric study of the posterior cranial fossa. J Neurosurg 86: 40-47.
16. Noudel R, Jovenin N, Eap C, Scherpereel B, Pierot L, et al. (2009) Incidence of basioccipital hypoplasia in Chiari malformation type I: comparative morphometric study of the posterior cranial fossa. Clinical article. J Neurosurg 111: 1046-1052.
17. Aydin S, Hanimoglu H, Tanriverdi T, Yentur E, Kaynar MY, (2005) Chiari type I malformations in adults: a morphometric analysis of the posterior cranial fossa. Surg Neurol 64: 237-241; discussion 241.
18. Schady W, Metcalfe RA, Butler P, (1987) The incidence of craniocervical bony anomalies in the adult Chiari malformation. J Neurol Sci 82: 193-203.
19. Karagoz F, Izgi N, Kapijcijoglu Sencer S, (2002) Morphometric measurements of the cranium in patients with Chiari type I malformation and comparison with the normal population. Acta Neurochir (Wien) 144: 165-171; discussion 171.
20. Milhorat TH, Nishikawa M, Kula RW, Dlugacz YD, (2010) Mechanisms of cerebellar tonsil herniation in patients with Chiari malformations as guide to clinical management. Acta Neurochir (Wien) 152: 1117-1127.
21. Stovner LJ, Bergan U, Nilsen G, Sjaastad O, (1993) Posterior cranial fossa dimensions in the Chiari I malformation: relation to pathogenesis and clinical presentation. Neuroradiology 35: 113-118.
22. Vega A, Quintana F, Berciano J, (1990) Basichondrocranium anomalies in adult Chiari type I malformation: a morphometric study. J Neurol Sci 99: 137-145.
23. Marin-Padilla M, (1991) Cephalic axial skeletal-neural dysraphic disorders: embryology and pathology. Can J Neurol Sci 18: 153-169.
24. Schanker BD, Walcott BP, Nahed BV, Kahle KT, Li YM, et al. (2011) Familial Chiari malformation: case series. Neurosurg Focus 31: E1.
25. Speer MC, Enterline DS, Mehltrette L, Hammock P, Judith Joseph MD, et al. (2003) Chiari Type I Malformation With or Without Syringomyelia: Prevalence and Genetics. Journal of Genetic Counseling 12: 297-311.
26. Fujita K, Aida N, Asakura Y, Kurosawa K, Niwa T, et al. (2009) Abnormal basiocciput development in CHARGE syndrome. AJNR Am J Neuroradiol 30: 629-634.
27. Wojcik C, Volz K, Ranola M, Kitch K, Karim T, et al. (2010) Rubinstein-Taybi syndrome associated with Chiari type I malformation caused by a large 16p13.3 microdeletion: a contiguous gene syndrome? American journal of medical genetics Part A 152A: 479-483.
28. Fujisawa H, Hasegawa M, Kida S, Yamashita J, (2002) A novel fibroblast growth factor receptor 2 mutation in Crouzon syndrome associated with Chiari type I malformation and syringomyelia. J Neurosurg 97: 396-400.
29. Schimmenti LA, Shim HH, Wirtschafter JD, Panzarino VA, Kashtan CE, et al. (1999) Homonucleotide expansion and contraction mutations of PAX2 and inclusion of Chiari 1 malformation as part of renal-coloboma syndrome. Hum Mutat 14: 369-376.
30. Boyles AL, Enterline DS, Hammock PH, Siegel DG, Slifer SH, et al. (2006) Phenotypic definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15. Am J Med Genet A 140: 2776-2785.
31. Kibar Z, Capra V, Gros P, (2007) Toward understanding the genetic basis of neural tube defects. Clinical genetics 71: 295-310.
32. Urbizu A, Poca M, Vidal X, Rovira A, Sahuquillo J, et al. (2012) MRI-based morphometric analysis of posterior cranial fossa: a probability model for diagnosis of Chiari malformation type I. Journal of Neuroimaging In press.
33. Miller SA, Dykes DD, Polesky HF, (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
34. Niederreither K, Dolle P, (2008) Retinoic acid in development: towards an integrated view. Nat Rev Genet 9: 541-553.
35. Bottcher RT, Niehrs C, (2005) Fibroblast growth factor signaling during early vertebrate development. Endocrine reviews 26: 63-77.
36. Shapiro R, Robinson F, (1976) Embryogenesis of the human occipital bone. AJR Am J Roentgenol 126: 1063-1068.
37. Kageyama R, Niwa Y, Shimojo H, (2009) Rhythmic gene expression in somite formation and neural development. Molecules and cells 27: 497-502.
38. Wittler L, Shin EH, Grote P, Kispert A, Beckers A, et al. (2007) Expression of Msgn1 in the presomitic mesoderm is controlled by synergism of WNT signalling and Tbx6. EMBO reports 8: 784-789.
39. Aulehla A, Pourquie O, (2009) Signaling gradients during paraxial mesoderm development. Cold Spring Harb Perspect Biol 2: a000869.
40. William DA, Saitta B, Gibson JD, Traas J, Markov V, et al. (2007) Identification of oscillatory genes in somitogenesis from functional genomic analysis of a human mesenchymal stem cell model. Developmental biology 305: 172-186.
41. Miura S, Davis S, Klingensmith J, Mishina Y, (2006) BMP signaling in the epiblast is required for proper recruitment of the prospective paraxial mesoderm and development of the somites. Development 133: 3767-3775.
42. Alexander T, Nolte C, Krumlauf R, (2009) Hox genes and segmentation of the hindbrain and axial skeleton. Annu Rev Cell Dev Biol 25: 431-456.
43. Olsen BR, Reginato AM, Wang W, (2000) Bone development. Annual review of cell and developmental biology 16: 191-220.
44. Monsoro-Burq AH, (2005) Sclerotome development and morphogenesis: when experimental embryology meets genetics. The International journal of developmental biology 49: 301-308.
45. Tribioli C, Lufkin T, (1999) The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development 126: 5699-5711.
46. Martin JF, Bradley A, Olson EN, (1995) The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages. Genes & development 9: 1237-1249.
47. Kaufmann P, Mayhew TM, Charnock-Jones DS, (2004) Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 25: 114-126.
48. Demir R, Kayisli UA, Seval Y, Celik-Ozenci C, Korgun ET, et al. (2004) Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. Placenta 25: 560-572.
49. Tubbs RS, Rutledge SL, Kosentka A, Bartolucci AA, Oakes WJ, (2004) Chiari I malformation and neurofibromatosis type 1. Pediatric neurology 30: 278-280.
50. Freeman AF, Davis J, Hsu AP, Holland SM, Puck JM (1993) Autosomal Dominant Hyper IgE Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews. Seattle (WA).
51. Gu CC, Yu K, Rao DC, (2008) Characterization of LD structures and the utility of HapMap in genetic association studies. Adv Genet 60: 407-435.
52. Thorisson GA, Smith AV, Krishnan L, Stein LD, (2005) The International HapMap Project Web site. Genome Res 15: 1592-1593.
53. Barnes MR, (2006) Navigating the HapMap. Brief Bioinform 7: 211-224.
54. Mueller JC, (2004) Linkage disequilibrium for different scales and applications. Brief Bioinform 5: 355-364.
55. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74: 106-120.
56. Lin CH, Yeakley JM, McDaniel TK, Shen R, (2009) Medium- to high-throughput SNP genotyping using VeraCode microbeads. Methods Mol Biol 496: 129-142.
57. Skol AD, Scott LJ, Abecasis GR, Boehnke M, (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38: 209-213.
58. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
59. Gonzalez JR, Armengol L, Sole X, Guino E, Mercader JM, et al. (2007) SNPassoc: an R package to perform whole genome association studies. Bioinformatics 23: 644-645.
60. Wickham H (2009) ggplot2: elegant graphics for data analysis. Springer, New York.
61. Storey JD, (2002) A direct approach to false discovery rates. Journal of the Royal Statistical Society, Series B 64 64: 479-498.
62. Boyles AL, Hammock P, Speer MC, (2005) Candidate gene analysis in human neural tube defects. American journal of medical genetics Part C, Seminars in medical genetics 135C: 9-23.
63. Kibar Z, Capra V, Gros P, (2007) Toward understanding the genetic basis of neural tube defects. Clin Genet 71: 295-310.
64. Greene ND, Stanier P, Copp AJ, (2009) Genetics of human neural tube defects. Human molecular genetics 18: R113-129.
65. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, et al. (1985) Retinoic acid embryopathy. The New England journal of medicine 313: 837-841.
66. Sandell LL, Sanderson BW, Moiseyev G, Johnson T, Mushegian A, et al. (2007) RDH10 is essential for synthesis of embryonic retinoic acid and is required for limb, craniofacial, and organ development. Genes & development 21: 1113-1124.
67. Duester G, (2008) Retinoic acid synthesis and signaling during early organogenesis. Cell 134: 921-931.
68. Kane WJ, (1977) Scoliosis prevalence: a call for a statement of terms. Clinical orthopaedics and related research pp. 43-46.
69. Houle M, Sylvestre JR, Lohnes D, (2003) Retinoic acid regulates a subset of Cdx1 function in vivo. Development 130: 6555-6567.
70. Houle M, Prinos P, Iulianella A, Bouchard N, Lohnes D, (2000) Retinoic acid regulation of Cdx1: an indirect mechanism for retinoids and vertebral specification. Molecular and cellular biology 20: 6579-6586.
71. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, et al. (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochemical and biophysical research communications 187: 1579-1586.
72. Demir R, Seval Y, Huppertz B, (2007) Vasculogenesis and angiogenesis in the early human placenta. Acta Histochem 109: 257-265.
73. Fong GH, Rossant J, Gertsenstein M, Breitman ML, (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70.
74. Xu Z, Taylor JA, (2009) SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic acids research 37: W600-605.